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OBJECTIVES We hypothesized that contrast-enhanced and dobutamine tagged magnetic resonance
imaging (MRI) could investigate microvascular integrity and contractile reserve of reperfused
myocardial infarction (MI) in one examination.
BACKGROUND In reperfused MI, microvascular integrity and contractile reserve are important determinants
of functional recovery.
METHODS Twenty-three patients with a reperfused first MI were studied. On day 3 6 1 after MI,
patients underwent tagged MRI at baseline and during infusion of 5 and 10 mg/kg/min of
dobutamine followed by contrast-enhanced MRI (first pass and delayed imaging) after a bolus
infusion of gadolinium-diethylenetriaminepenta-acetic acid. Tagged MRI was performed
9 6 1 weeks later (follow-up). Eighty-four transmural regions with hyperenhancement on
delayed contrast-enhanced images were defined as COMB (first pass hypoenhancement) or
HYPER (normal first pass signal enhancement). Percent circumferential segment shortening
was measured within the subendocardium and subepicardum of each region of HYPER or
COMB at baseline, peak dobutamine and follow-up.
RESULTS Shortening improved in COMB regions from 4 6 1% at baseline to 10 6 1% at peak
dobutamine and 10 6 1% at follow-up, respectively (p , 0.0003 vs. baseline for both). The
HYPER regions likewise improved from 10 6 1% at baseline to 16 6 1% and 17 6 1%,
respectively (p , 0.0004 vs. baseline for both). Function within COMB regions was less than
that of HYPER at baseline, peak dobutamine and follow-up (p , 0.0003 for all).
CONCLUSIONS Dobutamine magnetic resonance tagging and contrast enhanced MRI are complementary in
assessing functional recovery after reperfused MI. Regions of delayed contrast hyperenhance-
ment demonstrate both contractile reserve and late functional recovery. However, if these
regions demonstrate first pass contrast hypoenhancement, they are associated with greater
myocardial damage. (J Am Coll Cardiol 2000;36:1835–40) © 2000 by the American College
of Cardiology
After reperfusion of myocardial infarction (MI), variable
recovery of function may occur within “stunned” myocar-
dium (1). Several techniques can assess microvascular integ-
rity or contractile reserve as a means of predicting functional
recovery after reperfused MI. Measures of microvascular
integrity include contrast echocardiography (CE) (2,3) or
coronary flow measured by a Doppler coronary guidewire
(4) although this requires catheterization of the infarct-
related artery. Noninvasive measures include rest-
redistribution thallium (5), technetium-99m sestamibi mea-
sures of perfusion and function (6) and gadolinium-
diethylenetriaminepenta-acetic acid (Gd-DTPA) enhanced
magnetic resonance imaging (MRI) (7–9). Our group has
used the latter technique to identify contrast uptake patterns
and to correlate them with functional recovery (9). Imaging
techniques that examine contractile reserve, or wall thick-
ening in response to inotropic stimulation, to predict func-
tional recovery include dobutamine echocardiography (DE)
(10,11) and dobutamine cine MRI (12). Our group has used
dobutamine magnetic resonance (MR) tagging (13,14) to
demonstrate transmural differences in the predictive value of
contractile reserve after reperfused MI (15).
The ability to assess both properties of infarcted myocar-
dium has theoretic advantages over either alone (16) and can
be performed with echocardiography or MRI (17). Investi-
gators using echocardiography after MI (18) suggest that
CE and DE are complementary. However, image registra-
tion between techniques may be problematic, and specificity
of CE is limited. The goal of this study was to examine the
ability to predict functional recovery using: a) MRI contrast
uptake patterns and b) contractile response to dobutamine
by tagged MRI within the same myocardial tissue early after
reperfused first MI in a single noninvasive examination.
METHODS
Patient population. The Institutional Review Board of
Allegheny General Hospital approved the study, and all
human subjects gave informed consent. Twenty-seven pa-
tients with reperfused first MI were initially enrolled. The
diagnosis of MI was made in the conventional manner from
clinical history, electrocardiogram and plasma creatine ki-
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nase levels, drawn every 8 h, elevated to more than twice the
normal level with MB fraction .5%. All patients under-
went coronary angiography and either left ventriculography
or two-dimensional echocardiography before enrollment.
Patients with recent MI, documented open infarct-related
artery after thrombolytic therapy or primary angioplasty
with or without stenting and dysfunction in the infarct zone
documented by left ventriculography or echocardiography
were included in the study. All patients had documented
Thrombolysis in MI trial grade 3 flow in the infarct-related
artery after therapy. Exclusion criteria included patients
with postinfarction angina, active congestive heart failure,
atrial fibrillation, aortic stenosis, a history of sustained
ventricular arrhythmia, inability to lay flat or standard
contraindications to MRI such as pacemakers or cerebral
aneurysm clips.
Dobutamine tagging. After an 8-h fast, electro-
cardiogram-gated MRI was performed on a Siemens (Er-
langen, Germany) 1.5T Vision scanner with blood pressure
monitoring. All patients were placed supine with the chest
within a phased array surface chestcoil. Breath-hold tagged
imaging in the left ventricular short-axis from apex to base
was then performed (interframe delay 35 ms, repetition time
8 ms, echo time 1 ms, 7 line k-space segmentation, 8 mm
thick tag stripes, 7 mm thick slices, 126 3 256 matrix
interpolated to 256 3 256 for display, field of view 280 to
300 mm). The tagging method used was a grid-tagging
method (14). Signal from protons within the myocardium is
nulled in two sets of perpendicular lines at end-diastole,
enabling the tracking of intramyocardial points because the
signal remains nulled in these tagged lines through the
cardiac cycle as the myocardium deforms (Fig. 1). Breath-
hold duration was 18 heartbeats (15 s at the average heart
rate of the study patients). Dobutamine was infused at 5 and
10 mg/kg/min for a total of 5 min per stage, and apical,
midventricular and basal short-axis tagged imaging was
performed within the last 2.5 min of each 5-min period as
previously described (15) (Fig. 1, left, center).
Contrast enhanced imaging. Contrast enhanced imaging
was performed using an intravenous bolus of 0.1 mmol/kg
nonionic Gd-DTPA (gadoteridol, Bracco Diagnostics,
Princeton, New Jersey) at 5 cc/s using a power injector
(Spectris, Medrad, Indianola, Pennsylvania). T1-weighted
inversion-prepared Turboflash images were then sequen-
tially acquired at three locations beginning immediately
after contrast injection and lasting for 50 heartbeats. The
imaging period for the three slices was 855 ms, the repeti-
tion time 3.7 ms, echo time 1.2 ms, inversion time 150 ms,
matrix 80 3 128, slice thickness 10 mm and field of view
300 mm. The three slices imaged were two short-axis slices
(apex and midventricle for anterior infarctions and midven-
tricle and base for inferior infarctions at the same location as
the dobutamine tagged short-axis images) and one long-axis
image. At least 1 set of 10 delayed images in each of the same
three planes was acquired 5 to 7 min after the first pass imaging
described above (Fig. 2). Only the short-axis images were used
for analysis for direct comparison with the tagged imaging.
Follow-up imaging. The patients returned 9 6 1 weeks
after the MI for a repeat MRI that consisted of short-axis
MR tagging, as described above, without dobutamine. All
slices from apex to base were imaged (Fig. 1, right).
Image analysis. Because the first-pass and delayed contrast
imaging was performed without a breath-hold, we per-
formed automated in-plane registration and warping of the
short-axis images to correct for physiologic motion using an
algorithm developed in our laboratory (19). The first pass
images and a set of delayed enhancement images (the last if
more than one was performed) were reviewed in cine format
by two experienced, blinded reviewers for qualitative deter-
Abbreviations and Acronyms
CE 5 contrast echocardiography
COMB 5 myocardial regions demonstrating first pass
hypoenhancement and delayed
hyperenhancement
DE 5 dobutamine echocardiography
Gd-DTPA 5 gadolinium-diethylenetriaminepenta-acetic
acid
HYPER 5 myocardial regions demonstrating normal
first pass enhancement and delayed
hyperenhancement
MI 5 myocardial infarction
MR 5 magnetic resonance
MRI 5 magnetic resonance imaging
%S 5 percent intramyocardial circumferential
shortening
Figure 1. Left panel: End-systolic apical magnetic resonance tagged
short-axis image in a patient on day 3 after anterior myocardial infarction
treated with percutaneous transluminal coronary angioplasty and stenting
of the left anterior descending coronary artery. The septum lies between the
arrows, from 7 o’clock to 12 o’clock on the image. Note the reduced
deformation of the tag stripes in this region compared with that in the
anterolateral wall (12 o’clock to 4 o’clock) and inferoposterior wall (4
o’clock to 7 o’clock). Percent intramyocardial circumferential shortening
(%S) was 4% in the septal subendocardium and 3% in the septal
subepicardium. Center panel: End-systolic apical magnetic resonance
tagged short-axis image in the same patient at the end of the 10 mg/kg/min
dobutamine stage. Qualitatively, shortening increased significantly in the
anterolateral and inferoposterior regions, whereas no improvement is seen
in the septum (between the arrows). Quantitatively, %S was 5% in the
septal subendocardium and 1% in the septal subepicardium, neither of
which constitutes improvement. Right panel: End-systolic apical magnetic
resonance tagged short-axis image in the same patient at nine weeks after
myocardial infarction. Function did not improve in the septum (between
the arrows), either qualitatively or quantitatively, whereas deformation of
the tag stripes remains normal in the anterolateral and inferoposterior
regions. Percent shortening is 7% in the septal subendocardium and 2% in
the septal subepicardium—still significantly depressed. %S 5 percent
intramyocardial circumferential shortening.
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mination of abnormal contrast uptake patterns. Interobserver
agreement with these techniques and observers was excellent
(9). Myocardial regions (quadrants in the short-axis, for exam-
ple, anteroseptum, anterolateral, etc.) with hyperenhancement
through more than two-thirds of the transmural extent of the
wall on delayed postcontrast imaging were identified. Within
these regions, those demonstrating first pass hypoenhance-
ment, (seen generally in the subendocardial half of the myo-
cardium) were termed COMB. Those demonstrating normal
first pass enhancement were termed HYPER.
A blinded investigator (T.M.T.) performed quantitative
analysis of the percent of intramyocardial circumferential
shortening (%S) using previously published techniques
(9,15) and the VIDA software package (University of Iowa,
Iowa City, Iowa) on a Sun workstation. Measurements were
made on short-axis images within regions defined by ab-
normal contrast uptake patterns seen on contrast enhanced
imaging with two segments (subendocardial or subepicar-
dial) measured per region. A segment within a region was
defined as a line defined by a set of tag stripes perpendicular
to the endocardial surface in the subendocardium or sub-
epicardium. Percent shortening was measured within seg-
ments defined by these tag stripes as end-diastolic minus the
end-systolic interstripe distance divided by the end-diastolic
interstripe distance times 100 and expressed as a percentage.
Therefore, only end-diastolic and end-systolic images were
used to measure %S. Measurements were made at baseline
and at each dobutamine dose (5 and 10 mg/kg/min). The
peak response to dobutamine was recorded. Percent short-
ening was measured at nine weeks after MI from short-axis
slices matched to the day 3 post-MI study by apex to base
location, right ventricular insertion sites and papillary mus-
cles as previously performed (9,15).
Statistical analysis. Within each type of contrast defect,
%S was compared between baseline, peak dobutamine
response and follow-up using repeated measures analysis of
variance and Fisher subtesting. Previous work has estab-
lished a response to dobutamine of $5% as normal (15,20).
The improvement in %S from baseline to follow-up by
transmural region was compared by response to dobutamine
(normal or abnormal) and by contrast uptake pattern and
compared by unpaired t test. Linear regression analysis was
performed between %S at peak dobutamine and at follow-
up. The improvement in function (defined as an increase in
%S of $5% from baseline to follow-up) within regions of
the two types of contrast uptake patterns was evaluated.
Results are displayed as mean 6 standard error. A p value
,0.05 was considered to be statistically significant.
RESULTS
Four of the patients did not return for the follow-up MRI.
Therefore, 23 patients, 21 of whom were men, with a mean
age 51 6 2 years completed the study (Table 1). The initial
MRI was performed on day 3 6 1 after first reperfused acute
MI (13 anterior, 10 inferior). Three patients were treated
with thrombolytic therapy alone, 3 with thrombolytics
followed by rescue angioplasty and stenting, 6 with primary
angioplasty and 11 with primary angioplasty and stenting.
Peak CPK was 2,824 6 466. Twenty-one had Q wave and
two had non-Q wave infarctions. All patients had a patent
infarct related artery and TIMI grade 3 flow as documented
by coronary angiography before enrollment. All had docu-
mentation of regional left ventricular dysfunction within the
infarct zone by either left ventriculography or two-dimensional
echocardiography before enrollment. At the time of the first
MR study, all patients were taking aspirin; 19 were taking
beta-adrenergic blocking agents; 14 were taking angiotensin-
converting enzyme inhibitors, and 7 were taking nitrates.
No patients developed symptoms during or after the
dobutamine or the gadoteridol infusion. Heart rate did not
change during dobutamine (72 6 3 beats/min at baseline,
69 6 2 beats/min at 5 mg/kg/dobutamine, 72 6 3 beats/min
at 10 mg/kg/min dobutamine, p 5 NS). Likewise, blood
pressure did not change; 122 6 4/75 6 3 mm Hg at
baseline, 122 6 4/73 6 2 mm Hg at 5 mg/kg/min
dobutamine, 126 6 5/72 6 2 mm Hg at 10 mg/kg/min
dobutamine, p 5 NS.
The follow-up study was performed at 9 6 1 weeks after
the MI. None of the patients had interval cardiac events
between the two studies. The heart rate at the time of the 9
week study was 67 6 2, and blood pressure was 127 6
4/73 6 2 (p 5 NS from baseline study for both). At nine
weeks after MI, 21 patients were taking aspirin; 18 were
taking beta-blockers; 15 were taking angiotensin-converting
enzyme inhibitors, and two were taking nitrates.
Eighty-four transmural regions with an abnormal con-
trast pattern were identified, and, therefore, function in 168
segments (subendocardial and subepicardial) within these
regions was measured. In all 168 segments, %S was 6 6 1%
at baseline, 8 6 1% at 5 mg/kg/min dobutamine, 12 6 1%
at peak dobutamine (p , 0.0003 vs. baseline and 5 mg/kg/
Figure 2. Left panel: Short-axis inversion recovery Turboflash image
during first pass of gadolinium-diethylenetriaminepenta-acetic acid
through the myocardium in the same patient and the same apical short-axis
plane as in Figure 1 with the LV and RV as marked. Note the region of
hypoenhancement or reduced signal intensity between the arrows in the
septum. Right panel: Short-axis inversion recovery Turboflash image
5 min after bolus infusion of gadoteridol in same plane as panel A with the
LV and RV apex as marked. Note the hyperenhancement or increased
signal intensity of the septum between the arrows. The pattern demon-
strated in the two panels of this figure is consistent with that of the COMB
pattern (first pass hypoenhancement and delayed hyperenhancement).
LV 5 left ventricle; RV 5 right ventricle.
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min dobutamine) and 13 6 1% at follow-up (p , 0.0001 vs.
baseline and 5 mg/kg/min dobutamine). When improve-
ment was defined as a 5% increase in %S from baseline to
follow-up, 88 of 168 segments improved (52%).
The data as a whole is displayed in Table 2. Within
COMB regions, function improved significantly from 4 6
1% at baseline to 10 6 1% with peak dobutamine and 10 6
1% at follow-up (p 5 0.0002 vs. baseline for both). The
HYPER regions demonstrated significant improvement
from baseline (10 6 1%) to peak dobutamine (16 6 1%,
p , 0.0004) and follow-up (17 6 1%, p , 0.0004). Percent
shortening in HYPER regions was greater than COMB at
baseline, peak dobutamine and follow-up (p , 0.0003 for
each). The absolute increase in %S was similar in both
groups from baseline to follow-up (6 6 1% in COMB and
7 6 1% in HYPER).
Within subendocardial segments at baseline, %S was
higher in HYPER (12 6 1%) than it was in COMB (5 6
1%, p , 0.003) regions. A similar relationship was noted at
peak dobutamine (17 6 1% vs. 12 6 1%, p , 0.01) and at
follow-up (20 6 1% vs. 11 6 1%, p , 0.0001). Similarly,
within the subepicardium, %S in HYPER was greater than
it was in COMB regions at baseline (7 6 2% vs. 3 6 1%,
p , 0.03), peak dobutamine (14 6 2% vs. 7 6 2%, p ,
0.006) and at follow-up (13 6 1% vs. 8 6 2%, p , 0.03).
Of the 76 segments in HYPER regions, 46, or 60%,
improved %S at follow-up by 5%, whereas 43 of 92 (47%)
segments in COMB regions showed functional recovery at
follow-up. The improvement in %S from baseline to
follow-up in segments that responded normally to dobut-
amine (n 5 98) was 9 6 1% compared with 3 6 1% in
nonresponders (n 5 70, p 5 0.0002). There was a good
Table 1. Clinical Information for the 23 Study Patients
Patient # Age Gender Reperfusion Location Peak CK # of Regions
1 43 M Thrombolysis Anterior 1,525 4
2 47 M PTCA Anterior 1,055 4
3 61 M PTCA Inferior 2,460 4
4 54 F PTCA Anterior 1,452 4
5 54 M Thrombolysis Anterior 3,010 5
6 44 M Thrombolysis Inferior 2,172 4
7 39 M PTCA Anterior 2,082 3
8 43 M PTCA Anterior 4,440 4
9 62 M PTCA Inferior 214 3
10 51 M Thrombolysis Inferior 3,790 3
11 52 M PTCA Inferior 3,655 6
12 48 M PTCA Inferior 2,316 2
13 67 M PTCA Anterior 4,840 3
14 54 M PTCA Inferior 10,150 6
15 49 M PTCA Anterior 1,427 4
16 73 M Thrombolysis Anterior 3,540 6
17 34 M PTCA Anterior 2,556 4
18 41 M PTCA Inferior 1,039 3
19 67 M Thrombolysis Anterior 6,460 3
20 36 F PTCA Inferior 753 2
21 48 M PTCA Inferior 4,300 3
22 66 M PTCA Anterior 802 4
23 41 M PTCA Anterior 897 4
# of regions 5 number of regions with abnormal contrast uptake patterns. CK 5 creatine kinase; PTCA 5 percutaneous
transluminal coronary angiography
Table 2. Percent Circumferential Shortening in the 3 Types of Contrast Defects at Baseline on
Day 3, at Peak Dobutamine and at Follow-up on Week 9
Day 3
Peak
Dobutamine Week 9
ANOVA
p Value
COMB Endo 5 6 1% 12 6 1%* 11 6 1%* ,0.003
(n 5 92) Epi 3 6 1% 7 6 2%† 8 6 2%† ,0.03
Average 4 6 1% 10 6 1%* 10 6 1%* <0.001
HYPER Endo 12 6 2%‡ 17 6 2%*‡ 20 6 2%*‡ 50.0005
(n 5 76) Epi 5 6 1%‡ 12 6 1%*‡ 12 6 1%*‡ ,0.008
Average 10 6 1%‡ 16 6 1%*‡ 17 6 1%*‡ <0.001
Total Endo 8 6 1% 14 6 1%* 14 6 1%* ,0.0001
(n 5 168) Epi 5 6 1% 10 6 1%* 10 6 1%* ,0.001
Average 6 6 1% 12 6 1%* 13 6 1%* <0.0001
*p , 0.001 versus baseline; †p , 0.05 versus baseline; ‡p , 0.03 versus COMB.
ANOVA 5 analysis of variance; COMB 5 myocardial regions demonstrating first pass hypoenhancement and delayed
hyperenhancement; Endo 5 subendocardium; Epi 5 subepicardium; HYPER 5 myocardial regions demonstrating normal first
pass enhancement.
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correlation between follow-up %S and %S with peak do-
butamine (y 5 0.68x 1 4, r 5 0.62, p , 0.0001; Fig. 3).
DISCUSSION
This study demonstrates that both MRI contrast uptake
patterns and contractile response to dobutamine by tagged
MRI can be assessed early after reperfused first MI during
a single MRI examination. Both techniques impart infor-
mation about the potential of contractile recovery. Improve-
ment with dobutamine and at follow-up occurred within
both COMB and HYPER regions. The COMB regions
demonstrated lesser function at baseline, peak dobutamine and
follow-up, indicating that the presence of first pass hypoen-
hancement is associated with greater myocardial damage.
Absolute functional improvement in HYPER and COMB
were similar. Segments that respond normally to dobutamine
($5% increase in %S) showed greater late functional recovery
than segments that did not. Function at peak dobutamine
correlated well with function at rest at nine weeks after MI.
This data extends our group’s previous findings regarding
the implications of the contrast uptake patterns (9) and a
normal dobutamine response (15) for functional recovery.
The HYPER region represents predominantly viable myo-
cardium defined as both normal dobutamine response and
functional recovery in this setting. The COMB region repre-
sents a mixture of viable and nonviable tissue with some late
functional improvement. However, the presence of first pass
hypoenhancement reflects a greater extent of myocardial injury
than seen in HYPER regions. In addition, dobutamine-
recruitable function correlates with delayed function at rest.
Comparison with other studies using MRI. Previous
work in animal models suggest that contrast uptake patterns
reflect Gd-DTPA wash-in and washout kinetics (21).
Persistent hypoenhancement represents regions of no reflow
(22) and correlate with regions of hypoperfusion on contrast
echocardiography (23). In a canine model delayed hyperen-
hancement reflects infarct size although it overestimates it
by 12% (22). In man persistent hypoenhancement has been
associated with larger infarction with less adequate reperfu-
sion (8), worse short-term clinical markers (7), lack of
functional recovery (9) and worse long-term outcome (24).
The findings of delayed hyperenhancement are somewhat
more controversial as one study found an association of this
pattern with fixed defects on Tl-201 imaging (8) although
first pass imaging was not performed, and these may have
represented COMB regions. In the setting of chronic
ischemic heart disease, delayed hyperenhancement has been
shown to be a marker of nonviability, but principally in
akinetic or dyskinetic regions at rest (25).
One prior study compared contrast enhanced and dobut-
amine cine MRI in 28 postinfarction patients (26). In this
study no follow-up MRI was obtained to assess late func-
tional recovery, and first-pass uptake of Gd-DTPA was not
examined. Delayed imaging was performed 15 min after
contrast infusion. In regions with transmural delayed hy-
perenhancement, no dobutamine response was demon-
strated in 10 of 17 (59%) cases. Subendocardial hyperen-
hancement was associated with a normal dobutamine
response in 18 of 22 (82%) regions. Therefore, more
transmural hyperenhancement was associated with less do-
butamine response. In contrast, in this study, regions with
delayed hyperenhancement responded to dobutamine and
demonstrated late functional recovery. One potential expla-
nation for the difference is that some of the transmural
hyperenhanced regions in the study of Dendale et al. (26)
could have been hypoenhanced on first pass imaging had it
been performed and, therefore, would have represented
COMB regions rather than HYPER regions.
Comparison with echocardiography. Contrast and dobut-
amine echocardiography have been used together in several
studies. In a canine model of reperfused MI, Meza and
colleagues (27) demonstrated complementary utility of the two
techniques for identifying the absence of necrosis. Sensitivity
(88%) for viability was greater than the specificity (61%) of the
combined techniques. False positives in the study of Meza et
al. were mostly due to the preserved dobutamine response in
hypokinetic regions due to subendocardial infarction, as dem-
onstrated in previous work with both echocardiography (28)
and dobutamine MR tagging (15).
In 24 patients after MI, Iliceto et al. (18) compared CE
with low-dose DE. Contrast echocardiography was 100%
sensitive but only 46% specific for the assessment of viabil-
ity, whereas low-dose DE had a sensitivity of 71% and a
specificity of 88%. Dobutamine response and contractile
recovery were seen only in the group with preserved contrast
enhancement or microvascular integrity, similar to the
findings in all regions in this study in which contrast
eventually reaches the myocardium (delayed hyperenhance-
ment). Bolognese et al. (29) demonstrated comparable
findings in 30 patients after reperfused MI in that micro-
vascular integrity by CE was highly sensitive but nonspecific
for functional recovery. Dobutamine echocardiography was
Figure 3. Plot of linear regression analysis for %S at nine weeks after
myocardial infarction (follow-up) on the y-axis and at peak dobutamine at
day 3 after myocardial infarction for all 168 segments. A significant
correlation is demonstrated (y 5 0.68x 1 4, r 5 0.62, p , 0.0001). %S 5
percent intramyocardial circumferential shortening.
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more accurate for prediction of viability (90% vs. 47% for CE).
Microvascular integrity is, therefore, necessary but not suffi-
cient for functional recovery. The same is true for the COMB
regions in this study in which contrast eventually reaches the
microvasculature, but functional recovery is incomplete.
Study limitations. Findings of this study cannot be extrap-
olated to patients with a residual stenosis in the infarct-related
artery, to patients with chronic MI or to patients with less than
TIMI grade 3 flow after reperfusion. Only data from two
short-axis slices per patient were analyzed. Future improve-
ments in MR perfusion sequences will allow more extensive
coverage of the left ventricle. The perfusion imaging was
performed without a breath-hold, whereas the tagged imaging
was breath-hold, thereby creating a potential matching prob-
lem. However, the perfusion images were registered and
warped using an algorithm developed in our laboratory, allow-
ing careful matching of landmarks including apex to base
location, right ventricular insertion sites and papillary muscles.
Matching of the week 9 short-axis tagged images to the early
post-MI study is a potential limitation. However, as with
previous studies (9,15), careful matching of image locations
was used to ensure registration over time.
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